Buildit, here's my question. Generex will need money to fund their product line still. Their shares are class A I thought as well. So, wouldn't it be in their best interest to get those shares moved over to class B so they can sell chunks to fund operations?
Also, their 66 million or so shares in NGIO need to have value as well and if class A, then what value would they have if they can't be sold for 18 months?
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links